A detailed history of Sunpointe, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Sunpointe, LLC holds 4,350 shares of ABT stock, worth $512,256. This represents 0.41% of its overall portfolio holdings.

Number of Shares
4,350
Previous 4,055 7.27%
Holding current value
$512,256
Previous $421 Million 17.71%
% of portfolio
0.41%
Previous 0.27%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$100.07 - $118.13 $29,520 - $34,848
295 Added 7.27%
4,350 $496 Million
Q2 2024

Jul 19, 2024

SELL
$100.73 - $112.44 $20,548 - $22,937
-204 Reduced 4.79%
4,055 $421 Million
Q1 2024

Apr 15, 2024

BUY
$109.52 - $120.96 $12,375 - $13,668
113 Added 2.73%
4,259 $484 Million
Q4 2023

Feb 20, 2024

BUY
$90.19 - $110.4 $373,927 - $457,718
4,146 New
4,146 $456 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sunpointe, LLC Portfolio

Follow Sunpointe, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunpointe, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sunpointe, LLC with notifications on news.